Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Rangle who wrote (45548)	7/1/2012 9:05:41 PM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

Friday was the most insane end of quarter long side ramp I have seen in 30 years of trading. Gotta get that bonus! The air will come out soon.

To: Rangle who wrote (45548)	7/2/2012 9:13:31 AM
From: Rangle	Respond to of 48461

Futures are showing a slight bid as we start a holiday-shortened week. The quiet pre-market action follows a relatively quiet overnight session and a mixed performance in overseas markets, with strength in Europe and relatively unchanged action in Asia. Purchasing managers surveys were released in China and Europe. In China, the august index fell to 48.2 for June from 48.4 in May. In Europe, the index held at an already low 45.1 in June, unchanged from May. Today's U.S. economic calendar includes the June ISM Index and May Construction Spending data, both due out at 10:00 ET. The ISM index typically has more impact than Construction Spending. In U.S. corporate news, there were several major deals announced this morning. Quest Software (QSFT 27.76, -0.05) was acquired by Dell Inc. (DELL 12.51, +0.00) for $28 per share, representing a slight premium to Friday's closing price for Quest since the deal that had been widely rumored prior to this morning's announcement... Bristol-Myers Squibb (BMY 35.95, +0.00) will acquire Amylin Pharmaceuticals (AMLN 30.78, +2.58) for $31.00 per share in cash, representing an aggregate purchase price of ~$5.3 billion and 10% premium to Friday's closing price for Amylin. The total value of the transaction, including Amylin's net debt and a contractual payment obligation to Eli Lilly (LLY 42.91, 0.00) together totaling about $1.7 billion, is ~$7 billion... Additionally, Brightpoint (CELL 8.89, +3.48) will be acquired by Ingram Micro Inc. (IM 17.47, +0.00) for $9.00 per share in cash, representing a 66% premium to Friday's closing price for Brightpoint. The deal is expected to be accretive to Ingram's earnings per share by at least 18 cents in 2013 and 35 cents in 2014... Finally, Lincare Holdings (LNCR 41.20, +7.18) will be acquired by The Linde Group for $41.50 per share in cash, representing a 22% premium to Friday's closing price for Lincare. The total consideration of the transaction will be $4.6 billion. gl